Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Thoracic Surgery

  Free Subscription

Articles published in Thromb Haemost

Retrieve available abstracts of 13 articles:
HTML format
Text format

Single Articles

    October 2018
  1. SORRENTINO S, Baber U, Claessen BE, Camaj A, et al
    Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Oct 12. doi: 10.1055/s-0038-1673687.
    PubMed     Text format     Abstract available

    August 2018
  2. KARHAUSEN JA, Qi W, Smeltz AM, Li YJ, et al
    Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667199.
    PubMed     Text format     Abstract available

    Life-Saving Therapy versus Symptom Relief: Anti-Platelet Agents and Opioids in Coronary Intervention.
    Thromb Haemost. 2018;118:1350-1351.
    PubMed     Text format    

    June 2018
  4. SUMAYA W, Parker WAE, Fretwell R, Hall IR, et al
    Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study).
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1657768.
    PubMed     Text format     Abstract available

  5. ALEXOPOULOS D, Xenogiannis I, Vlachakis P, Tantry U, et al
    Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Jun 4. doi: 10.1055/s-0038-1649484.
    PubMed     Text format     Abstract available

  6. WILLEMSEN L, Ten Berg J
    Platelet Inhibition and Bleeding Risks in Patients Undergoing Non-Cardiac Surgery.
    Thromb Haemost. 2018;118:953-955.
    PubMed     Text format    

    April 2018
  7. MAHLA E, Metzler H, Bornemann-Cimenti H, Prueller F, et al
    Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Thromb Haemost. 2018 Apr 6. doi: 10.1055/s-0038-1641153.
    PubMed     Text format     Abstract available

  8. BOURGUIGNON T, Bernard A, Fauchier L
    Risk of Thromboembolic Events without Oral Anticoagulation at 90 Days after Surgical Aortic Valve Replacement with a Bioprosthesis.
    Thromb Haemost. 2018 Apr 4. doi: 10.1055/s-0038-1641167.
    PubMed     Text format    

    March 2018
  9. KIBLER M, Marchandot B, Messas N, Caspar T, et al
    CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement.
    Thromb Haemost. 2018 Mar 28. doi: 10.1055/s-0038-1639352.
    PubMed     Text format     Abstract available

    January 2018
  10. PAWLITSCHEK F, Keyl C, Zieger B, Budde U, et al
    Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation.
    Thromb Haemost. 2018;118:103-111.
    PubMed     Text format     Abstract available

    December 2017
  11. HEWING B, Ellerbroek R, Au SC, Stangl V, et al
    Levels of Circulating Intermediate Monocytes Decrease after Aortic Valve Replacement in Patients with Severe Aortic Stenosis.
    Thromb Haemost. 2017;117:2346-2355.
    PubMed     Text format    

    February 2017
  12. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
    Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
    Thromb Haemost. 2017;117:445-456.
    PubMed     Text format     Abstract available

  13. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.